Status:
NOT_YET_RECRUITING
Primitive Immunodeficiency, Intrauterine Devices and Menstrual Hygiene Products
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
URC-CIC Paris Descartes Necker Cochin
Conditions:
Primary Immune Deficiency Diseases
Eligibility:
FEMALE
18+ years
Brief Summary
Primary immune deficiency diseases (PIDDs) constitute a large group of genetic disorders of the immune system which associates to varying degrees an increased susceptibility to infections and immuno-p...
Detailed Description
Primary immune deficiency diseases (PIDDs) constitute a large group of genetic disorders of the immune system which associate to varying degrees an increased susceptibility to infections and immuno-pa...
Eligibility Criteria
Inclusion
- Adult woman with primary immune deficiency disease and registered in the reference Center for Hereditary Immune Deficits (CEREDIH, hospital Necker-Enfants Malades, Paris)
- Patient not opposed to participation in research
Exclusion
- Refusal to participate of the study
- Deceased patient
- Minor patient
- Patient under legal protection
Key Trial Info
Start Date :
October 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06519734
Start Date
October 1 2025
End Date
April 1 2026
Last Update
September 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Necker-Enfants Malades
Paris, France, 75015